Phase II Trial of Paricalcitol and Hydroxychloroquine (PH) Combination With Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
Summary
The purpose of this phase II trial is to evaluate the safety and efficacy paricalcitol and hydroxychloroquine in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer.
General Information
NCT#: NCT04524702
Study ID: STUDY00000996
Trial Phase: Phase II
Trial Sponsor: Emory University
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, Hydroxychloroquine, Paricalcitol